Zhejiang Jingxin Pharmaceutical Co., Ltd. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Jingxin Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
Xiamen Kingdomway Group Co
sales of 1.20 billion Chinese Renmimbi [US$174.78 million]
of which 99%
was Bio-Pharmaceutical Products),
Zhejiang Jiuzhou Pharmaceutical Co Ltd
(1.44 billion Chinese Renmimbi [US$209.71 million]
of which 92%
was Production and sale of chemical active p), and
Tianjin Tianyao Pharmaceutical, Ltd.
(1.40 billion Chinese Renmimbi [US$203.94 million]
Zhejiang Jingxin Pharmaceutical Co., Ltd. reported sales of 1.41 billion Chinese Renmimbi (US$205.38 million)
December of 2015.
increase of 14.6%
versus 2014, when the company's sales were 1.23 billion Chinese Renmimbi.
Sales at Zhejiang Jingxin Pharmaceutical Co., Ltd. have increased during each of the previous five years
(and since 2010, sales have increased a total of 124%).
Sales of Medicines On Sale saw an increase
14.9% in 2015, from
1.21 billion Chinese Renmimbi to 1.39 billion Chinese Renmimbi.
Not all segments of Zhejiang Jingxin Pharmaceutical Co., Ltd. experienced an increase in sales in 2015:
sales of Other Operations fell 4.0% to 21.82 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).